IMC Chicago
NVAX icon

IMC Chicago’s Novavax NVAX Stock Holding History

IMC Chicago’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.05M Sell
497,600
-85,300
-15% -$773K ﹤0.01% 1969
2025
Q4 		$3.92M Sell
582,900
-138,000
-19% -$1.04M ﹤0.01% 1911
2025
Q3 		$6.25M Buy
720,900
+123,600
+21% +$962K ﹤0.01% 1424
2025
Q2 		$3.76M Buy
597,300
+263,700
+79% +$1.75M ﹤0.01% 1578
2025
Q1 		$2.14M Buy
333,600
+99,200
+42% +$820K ﹤0.01% 1761
2024
Q4 		$1.88M Hold
234,400
– – ﹤0.01% 1919
2024
Q3 		$2.96M Sell
234,400
-65,400
-22% -$844K ﹤0.01% 1428
2024
Q2 		$3.8M Buy
299,800
+201,400
+205% +$2.03M ﹤0.01% 1192
2024
Q1 		$470K Sell
98,400
-324,900
-77% -$1.51M ﹤0.01% 2067
2023
Q4 		$2.03M Sell
423,300
-84,800
-17% -$519K ﹤0.01% 1208
2023
Q3 		$3.68M Sell
508,100
-74,700
-13% -$597K ﹤0.01% 819
2023
Q2 		$4.33M Sell
582,800
-444,400
-43% -$3.49M ﹤0.01% 705
2023
Q1 		$7.12M Buy
1,027,200
+49,600
+5% +$456K 0.01% 577
2022
Q4 		$10M Buy
977,600
+81,800
+9% +$1.44M 0.02% 456
2022
Q3 		$16.3M Buy
895,800
+398,900
+80% +$17.3M 0.02% 335
2022
Q2 		$25.6M Sell
496,900
-34,400
-6% -$1.78M 0.04% 233
2022
Q1 		$39.1M Sell
531,300
-207,500
-28% -$18.5M 0.04% 206
2021
Q4 		$106M Buy
738,800
+415,300
+128% +$71.4M 0.09% 93
2021
Q3 		$67.1M Sell
323,500
-34,000
-10% -$7.49M 0.07% 136
2021
Q2 		$75.9M Buy
357,500
+55,400
+18% +$10.2M 0.09% 118
2021
Q1 		$54.8M Buy
302,100
+101,700
+51% +$20.3M 0.08% 136
2020
Q4 		$22.3M Sell
200,400
-11,400
-5% -$1.21M 0.03% 253
2020
Q3 		$22.9M Buy
211,800
+74,100
+54% +$9.03M 0.04% 180
2020
Q2 		$11.5M Buy
+137,700
New +$5.27M 0.02% 243

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

IMC Chicago's NVAX Position: Q1 2026 in Review

IMC Chicago sold out of Novavax (NVAX) in Q1 2026, closing a stake of 78,083 shares — an estimated $708K sold.

IMC Chicago first reported a position in NVAX in Q2 2020 and held it in 10 quarters. The position peaked at $11.1M in Q3 2021. 257 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

  • IMC Chicago reported no remaining Novavax position as of Q1 2026 after selling out during the quarter.
  • IMC Chicago sold 78,083 Novavax shares in Q1 2026, an estimated $708K.
  • IMC Chicago first reported a position in Novavax in Q2 2020 and held it in 10 quarters.
  • IMC Chicago's Novavax position peaked at $11.1M in Q3 2021.
  • 257 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.